Current Size: 100%

News

Wilhelm-Türk-Prize 2016 back to LBC ONC

The Wilhelm Turk Prize of the Austrian Society for Hematology & Medical Oncology (OeGHO) has been awarded to DI. Dr. Katharina Blatt, from the working group of Univ.-Prof. Dr. Peter Valent (Ludwig Boltzmann Cluster Oncology), in the context of the joint annual meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology, which took place in Leipzig in mid-October 2016.

Workshop on Normal and Neoplastic Erythropoiesis 28. April 2017

In April 2017 in collaboration with the Medical University of Vienna and the Vienna Cancer Stem Cell Club (VCSCC), members of the Ludwig Boltzmann Cluster Oncology (LBC ONC) organized a Workshop dedicated to erythropoiesis: ´Normal and Neoplastic Erythropoiesis: From Gene Regulation to Targeted Treatment Concepts’. The meeting took place in the Lecture Center (Hörsaal-Zentrum – KR21) of the Medical University of Vienna (General Hospital of Vienna – AKH) on Friday April 28, 2017, from 8:00 AM to 7:00 PM. There will be no registration or registration fee.

Jubilee Fund of the Mayor of the City of Vienna

It has been known for many years that there are gender-specific risk profiles in various myeloid leukemias, and the prognosis often differs considerably when comparing male and female patient groups. In order to investigate the mechanisms of this phenomenon, the Ludwig-Boltzmann Cluster Oncology has defined a project in which leukemic stem cells and the stem cell niche are to be investigated. The application has been submitted for the Jubilee Fund of the Vienna City Mayor and has recently been approved.

Comparative Oncology 24 March 2017

On March 24, 2017, the Comparative Oncology Mast Cell Meeting will be held under the motto "Bridging the Gap" at the Vienna Veterinary University.

National and international experts will present their most recent data on the development of novel therapies for mast cell neoplasms in humans and dogs.

The Comparative Oncology places its efforts in bridging the gap between the veterinary and human medicine, by using synergistic effects of comparative research, in order to improve therapy for humans as well as pets.

This one-day meeting connects scientists from many disciplines - from molecular biology to clinics - and shall present an extensive picture of neoplastic mast cell research and provide an overview of the current targeted therapies available in the veterinary area.

This meeting is free and open to all without prior registration.

ASH Meeting December 2016

The annual meeting of the American Society for Hematology (ASH) was held in San Diego, California, at the beginning of December 2016 (3.12-6.12.2016). A total of 28,000 participants were present (counted), mainly specialist physicians, but also fundamental researchers and representatives of the pharmaceutical industry. Among the countless international experts a strong Austrian participation with numerous oral and poster presentations has been noted. Representatives of the Ludwig Boltzmann Cluster Oncology (LBC ONC) and the Medical University of Vienna (MUV) were also able to present their data during this important meeting, highlighting two register studies in the area of ​​myeloid neoplasms (chronic myelomonocytic leukemia, CMML and mastocytosis).

OeGHO Spring Conference 2016

The spring meeting of the Austrian Society for Hematology & Medical Oncology took place from 17-19. March 2016 in Hofburg Vienna. Members of the Ludwig Boltzmann Cluster Oncology (LBC ONC) were represented with numerous posters and lectures. A poster designed by Heidrun Karlic in cooperation with the LBI for Osteology (working group of Franz Varga) was also presented as a lecture in the "Best Abstracts Session". The new findings on the interaction of leukemia stem cells and bone cells presented at this conference were published in the journal JATROS (issue of May 2016).

Wilhelm Tuerk Award of the OEGHO goes to LBC ONC Scientists

The Wilhelm Tuerk Award OEGHO 2015 was conferred to Irina Sadovnik (Medical University of Vienna) and Harald Herrmann (Ludwig Boltzmann Cluster Oncology, Medical University of Vienna). The publication entitled 'Dipeptidylpeptidase IV (CD26) Defines Leukemic Stem Cells (LSC) in Chronic Myeloid Leukemia' (Blood 2014; 123: 3951-3962), which includes the phenotypic and functional characterization of leukemic stem cells in the Ph + CML, was honoured.

The project was conducted within the scope of the Ludwig Boltzmann Cluster Oncology (LBC ONC) at the Medical University of Vienna (MUW). The data has already been presented and awarded several times at international congresses.

Symposium: In Memoriam Paul Ehrlich in August 2015

The four-day meeting consisted of two parts. The Memorial Symposium on the first day (20 August 2015 in the Van Swieten Hall of the Medical University of Vienna) was freely accessible to all interested parties. It was devoted to the life and scientific achievements of Paul Ehrlich and his visions, but also illuminated the scientific excellence of the Viennese research community resulting from these visions in the last 30 years.

Obituary - Dr. Sabine Cerny-Reiterer

The Ludwig Boltzmann Cluster Oncology mourns his colleague, Dr. Sabine Cerny-Reiterer, who died unexpectedly and suddenly in late November. Dr. Sabine Cerny-Reiterer has worked as a senior scientist at the Ludwig Boltzmann Cluster Oncology at the Medical University of Vienna since 2011. Sabine Cerny-Reiterer was not only an outstanding and engaged above-average scientist, who was active in the field of leukemia and stem cell research, but also a popular, well-known and appreciated personality for her many positive character traits.

Pages